phenobarbital sodium contraindications for Dummies
phenobarbital sodium contraindications for Dummies
Blog Article
pentobarbital will reduce the level or effect of naloxegol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with robust CYP3A4 inducers is not suggested
Contraindicated (1)pentobarbital will lower the level or effect of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is answerable for the formation and elimination of cariprazine's Energetic metabolites.
Since these clients may be fewer aware about particular on the milder adverse effects of barbiturates, the incidence of such reactions could be somewhat bigger in totally ambulatory patients.
Administer barbiturates with warning in patients with hepatic damage and at minimized doses to begin with; barbiturates shouldn't be administered to people exhibiting the premonitory signs of hepatic coma
pentobarbital will minimize the extent or effect of atorvastatin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the level or effect of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Avoid coadministration of bedaquiline with powerful CYP3A4 inducers as a result of probable for reduced therapeutic effect
pentobarbital will decrease the level or effect of cinacalcet by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital check here will reduce the extent or effect of sufentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.
pentobarbital will lessen the level or effect of zaleplon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unidentified.
pentobarbital will decrease the extent or effect of ambrisentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Mysterious.
pentobarbital will reduce the level or effect of piroxicam by affecting hepatic enzyme CYP2C9/10 metabolism. Small/Significance Unidentified.
pentobarbital will minimize the level or effect of colchicine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital and olopatadine intranasal equally increase sedation. Prevent or Use Alternate Drug. Coadministration improves chance of CNS depression, which can lead to additive impairment of psychomotor functionality and trigger daytime impairment.
pentobarbital will decrease the level or effect of dutasteride by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.